乳腺癌保乳术后化疗患者的抑郁、焦虑状况调查分析  

Survey and Analysis of Depression and Anxiety of the Patients with Breast Cancer Conserving Surgery plus Postoperative Chemotherapy

作　　者：李静[1] 李红[1] 李亚楠[1] 

机构地区：[1]郑州大学第一附属医院,河南郑州450052

出　　处：《肿瘤基础与临床》2013年第3期236-238,共3页journal of basic and clinical oncology

摘　　要：目的分析乳腺癌保乳术后化疗患者抑郁、焦虑状况及影响因素,为促进其积极应对负性情绪提供临床对策。方法利用自制问卷、SDS抑郁量表和SAS焦虑量表对200例乳腺癌保乳术后化疗患者进行问卷调查。结果本次调查共发放问卷200份,回收有效问卷197份,有效率98.50%。在被调查的197例患者中,抑郁发生率38.58%(76/197),焦虑发生率47.72%(94/197),抑郁焦虑共病发生率18.27%(36/197)。影响乳腺癌保乳术后化疗患者抑郁、焦虑和抑郁焦虑共病发生的主要因素包括年龄、学历、化疗次数、肿瘤分期、有无配偶。结论乳腺癌保乳术后化疗患者的抑郁、焦虑及抑郁焦虑共病发生率较高,临床实践中应制定个体化心理疏导方案,以利于患者的康复。Objective To analyze the depressions and anxieties of patients with breast cancer conserving surgery plus postoperative chemotherapy, and to provide the helpful chnical measures for healthcares improving the negative emotions of the patients. Methods The self-made questionnaire, self-rating depression scale and self-rating anxiety scale were used in the survey of 200 cases of breast cancer with breast cancer conserving surgery plus postoperative chemotherapy. Results The 197 copies of effective questionnaires were recycled from the 200 surveyed questionnaires,and the effective rate was 98.50%. In the surveyed 197 patients, the rate of depression was 38.58% （76/197）, the rate of anxiety was 47.72% （94/197）, the anxiety depression co-morbidity rate was 18.27% （36/197）. The major factors of depression, anxiety and anxiety depression co-morbidity of patients with breast cancer conserving surgery plus postoperative chemotherapy were age, education background, the number of chemotherapy, tumor staging, partner. Conclusion It is found that the patients with breast cancer conserving surgery plus post-operative chemotherapy have high rate of depression, anxiety and the anxiety depression co-morbidity, and the individualized psychological counseling program should be implemented to facilitate the rehabilitation of the patients in the clinical practice.

关 键 词：乳腺癌 保乳术 化疗 抑郁 焦虑 

分 类 号：R737.9[医药卫生—肿瘤] R730.53[医药卫生—临床医学]